Claire L Russell1, Amanda Heslegrave2, Vikram Mitra1, Henrik Zetterberg2,3, Jennifer M Pocock3, Malcolm A Ward1, Ian Pike1. 1. Proteome Sciences plc, Institute of Psychiatry, Kings College London, South Wing Laboratories, De Crespigny Park, London, SE5 8AF, UK. 2. Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. 3. Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Abstract
RATIONALE: Ideal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low-abundance markers due to the high dynamic range of proteins, the predominance of hyper-abundant proteins, and the use of data-dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator™; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low-abundance, tissue-derived biomarkers. METHODS: A disease relevant cell line was labelled with TMT® in a range of concentrations generating a multi-point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID-HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non-depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15 hours of MS time, equivalent to 1.5 h per sample. RESULTS: Using the TMTcalibrator™ workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. CONCLUSIONS: This study has demonstrated the benefits of the new TMTcalibrator™ workflow and the results suggest this is a suitable and efficient method of detecting low-abundance peptides within biological fluids. The use of TMTcalibrator™ in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches.
RATIONALE: Ideal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low-abundance markers due to the high dynamic range of proteins, the predominance of hyper-abundant proteins, and the use of data-dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator™; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low-abundance, tissue-derived biomarkers. METHODS: A disease relevant cell line was labelled with TMT® in a range of concentrations generating a multi-point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID-HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non-depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15 hours of MS time, equivalent to 1.5 h per sample. RESULTS: Using the TMTcalibrator™ workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. CONCLUSIONS: This study has demonstrated the benefits of the new TMTcalibrator™ workflow and the results suggest this is a suitable and efficient method of detecting low-abundance peptides within biological fluids. The use of TMTcalibrator™ in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches.
Authors: Lian Yi; Chia-Feng Tsai; Ercument Dirice; Adam C Swensen; Jing Chen; Tujin Shi; Marina A Gritsenko; Rosalie K Chu; Paul D Piehowski; Richard D Smith; Karin D Rodland; Mark A Atkinson; Clayton E Mathews; Rohit N Kulkarni; Tao Liu; Wei-Jun Qian Journal: Anal Chem Date: 2019-03-15 Impact factor: 6.986
Authors: Kei G I Webber; Thy Truong; S Madisyn Johnston; Sebastian E Zapata; Yiran Liang; Jacob M Davis; Alexander D Buttars; Fletcher B Smith; Hailey E Jones; Arianna C Mahoney; Richard H Carson; Andikan J Nwosu; Jacob L Heninger; Andrey V Liyu; Gregory P Nordin; Ying Zhu; Ryan T Kelly Journal: Anal Chem Date: 2022-04-06 Impact factor: 8.008
Authors: Bin Fang; Victoria Izumi; Lily L Remsing Rix; Eric Welsh; Ian Pike; Gary W Reuther; Eric B Haura; Uwe Rix; John M Koomen Journal: Proteomics Date: 2020-09-30 Impact factor: 3.984
Authors: Maowei Dou; Geremy Clair; Chia-Feng Tsai; Kerui Xu; William B Chrisler; Ryan L Sontag; Rui Zhao; Ronald J Moore; Tao Liu; Ljiljana Pasa-Tolic; Richard D Smith; Tujin Shi; Joshua N Adkins; Wei-Jun Qian; Ryan T Kelly; Charles Ansong; Ying Zhu Journal: Anal Chem Date: 2019-09-25 Impact factor: 6.986
Authors: Erwin M Schoof; Benjamin Furtwängler; Nil Üresin; Nicolas Rapin; Simonas Savickas; Coline Gentil; Eric Lechman; Ulrich Auf dem Keller; John E Dick; Bo T Porse Journal: Nat Commun Date: 2021-06-07 Impact factor: 14.919